This Article Full Text Full Text (PDF) All Versions of this Article: 23/12/e57    most recent 01.ATV.0000107029.65274.dbv1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by George, J. Articles by Keren, G. Search for Related Content PubMed PubMed Citation Articles by George, J. Articles by Keren, G. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Stem Cells Related Collections Restenosis Endothelium/vascular type/nitric oxide

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:e57.)
© 2003 American Heart Association, Inc.

Vascular Biology

Number and Adhesive Properties of Circulating Endothelial Progenitor Cells in Patients With In-Stent Restenosis

Jacob George; Itzhak Herz; Emil Goldstein; Soulico Abashidze; Varda Deutch; Ariel Finkelstein; Yoav Michowitz; Hylton Miller; Gad Keren

From the Department of Cardiology (J.G., I.H., E.G., S.A., A.F., Y.M., H.M., G.K.) and the Hematology Institute (V.D.), Tel Aviv Sourasky Medical Center, and The Sackler Faculty of Medicine, Tel Aviv University, Israel.

Correspondence to Jacob George, MD, The Department of Cardiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. E-mailjacobg{at}post.tau.ac.il

Objective— Intact endothelialization machinery is essential to facilitate vessel healing after stent placement and to prevent restenosis. Circulating endothelial progenitor cells (EPC) have been demonstrated in the peripheral blood and shown to display endothelial functional properties, along with the ability to traffic to damaged vasculature. We reasoned that robust in-stent intimal growth could be partially related to impaired endothelialization resulting from reduced circulating EPC number or function.

Methods and Results— Sixteen patients with angiographically-demonstrated in-stent restenosis were compared with patients with a similar clinical presentation that exhibited patent stents (n=11). Groups were similar with respect to the use of drugs that could potentially influence EPC numbers. Circulating EPC numbers were determined by the colony-forming unit assay, and their phenotype was characterized by endothelial-cell markers. Adhesiveness of EPC from both groups to extracellular matrix and to endothelial cells was also assayed. Patients with in-stent restenosis and with patent stents displayed a similar number of circulating EPC. Fibronectin-binding was compromised in patients with in-stent restenosis as compared with their controls exhibiting patent stents. Patients with diffuse in-stent restenosis exhibited reduced numbers of EPC in comparison with subjects with focal in-stent lesions.

Conclusion— Reduced numbers of circulating EPC in patients with diffuse in-stent restenosis and impaired adhesion of EPC from patients with restenosis provides a potential mechanism mediating the exuberant proliferative process. These markers, if further validated, could provide means of risk stratifying patients for likelihood of developing in-stent restenosis.

Key Words: endothelial progenitor cell • stem-cell • restenosis • stent • endothelium

This article has been cited by other articles:

				M. A.M. Beijk, M. Klomp, N. J.W. Verouden, N. van Geloven, K. T. Koch, J. P.S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, et al. GenousTM endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study Eur. Heart J., November 18, 2009; (2009) ehp476v1. [Abstract] [Full Text] [PDF]

				B. Hibbert, X. Ma, A. Pourdjabbar, E. Holm, K. Rayner, Y.-X. Chen, J. Sun, L. Filion, and E. R. O'Brien Inhibition of endothelial progenitor cell glycogen synthase kinase-3{beta} results in attenuated neointima formation and enhanced re-endothelialization after arterial injury Cardiovasc Res, July 1, 2009; 83(1): 16 - 23. [Abstract] [Full Text] [PDF]

				K. Yamahara and H. Itoh Potential use of endothelial progenitor cells for regeneration of the vasculature Therapeutic Advances in Cardiovascular Disease, February 1, 2009; 3(1): 17 - 27. [Abstract] [PDF]

				W Wojakowski, M Kucia, M Kazmierski, M Z Ratajczak, and M Tendera Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart, January 1, 2008; 94(1): 27 - 33. [Abstract] [Full Text] [PDF]

				Y. Michowitz, E. Goldstein, D. Wexler, D. Sheps, G. Keren, and J. George Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure Heart, September 1, 2007; 93(9): 1046 - 1050. [Abstract] [Full Text] [PDF]

				R. M Cubbon, A. Rajwani, and S. B Wheatcroft The impact of insulin resistance on endothelial function, progenitor cells and repair Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 103 - 111. [Abstract] [PDF]

				E. Shantsila, T. Watson, and G. Y.H. Lip Endothelial Progenitor Cells in Cardiovascular Disorders J. Am. Coll. Cardiol., February 20, 2007; 49(7): 741 - 752. [Abstract] [Full Text] [PDF]

				S. Wassmann, N. Werner, T. Czech, and G. Nickenig Improvement of Endothelial Function by Systemic Transfusion of Vascular Progenitor Cells Circ. Res., October 13, 2006; 99(8): E74 - E83. [Abstract] [Full Text] [PDF]

				S. Hamed, I. Barshack, G. Luboshits, D. Wexler, V. Deutsch, G. Keren, and J. George Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy Eur. Heart J., August 1, 2006; 27(15): 1876 - 1883. [Abstract] [Full Text] [PDF]

				J. George, A. Afek, A. Abashidze, H. Shmilovich, V. Deutsch, J. Kopolovich, H. Miller, and G. Keren Transfer of Endothelial Progenitor and Bone Marrow Cells Influences Atherosclerotic Plaque Size and Composition in Apolipoprotein E Knockout Mice Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2636 - 2641. [Abstract] [Full Text] [PDF]

				J. George, E. Goldstein, A. Abashidze, D. Wexler, S. Hamed, H. Shmilovich, V. Deutsch, H. Miller, G. Keren, and A. Roth Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI 3-kinase-dependent manner Cardiovasc Res, November 1, 2005; 68(2): 299 - 306. [Abstract] [Full Text] [PDF]

				N. Werner, S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta, A. Link, M. Bohm, and G. Nickenig Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes N. Engl. J. Med., September 8, 2005; 353(10): 999 - 1007. [Abstract] [Full Text] [PDF]

				M. Ruel, E. J. Suuronen, J. Song, V. Kapila, D. Gunning, G. Waghray, F. D. Rubens, and T. G. Mesana Effects of off-pump versus on-pump coronary artery bypass grafting on function and viability of circulating endothelial progenitor cells J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 633 - 639. [Abstract] [Full Text] [PDF]

				V. J. Dzau, M. Gnecchi, A. S. Pachori, F. Morello, and L. G. Melo Therapeutic Potential of Endothelial Progenitor Cells in Cardiovascular Diseases Hypertension, July 1, 2005; 46(1): 7 - 18. [Abstract] [Full Text] [PDF]

				J. George, E. Goldstein, S. Abashidze, V. Deutsch, H. Shmilovich, A. Finkelstein, I. Herz, H. Miller, and G. Keren Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation Eur. Heart J., June 2, 2004; 25(12): 1003 - 1008. [Abstract] [Full Text] [PDF]